Search

Biocompatible iron oxide nanoparticles (IONPs) were utilized for charge-based selective capture of the cationic bacteriocin pediocin secreted by food-grade lactic acid bacteria (LAB), resulting in the generation of a nanocomposite, which could be readily separated from other secreted metabolites. Interestingly, pediocin activity was conserved and a membrane-directed antibacterial activity typically associated with pediocin was manifested in the nanocomposite. Efficient sequestration of pediocin was also achieved through facile magnetic separation of IONP–pediocin composites and following desorption at pH 2.0, the recovered IONPs could be recycled for a subsequent round of pediocin adsorption. The steady state adsorption isotherm of pediocin with IONPs followed a Langmuir isotherm model. Following the reversible adsorption–desorption process with IONPs, 16-fold purification of pediocin could be achieved. The HPLC profile of the desorbed pediocin revealed a similar retention time to pediocin purified by an established cell-adsorption method and the HPLC eluted fraction also displayed the signature membrane-directed pediocin activity. The facile capture of pediocin, magnetic separation and the possibility of salvaging IONPs for reuse, accompanied by high retention of pediocin activity during the purification process, enhance the merit of IONPs as robust and effective purification tools for a potentially therapeutic antimicrobial peptide.

It is reported that glucose oxidase (GOx)-copper hybrid nanoflowers embedded with Fe3 O4 magnetic nanoparticles (MNPs) exhibit superior peroxidase-mimicking activity as well as substrate channeling for glucose detection. This is due to the synergistic integration of GOx, crystalline copper phosphates and MNPs being in close proximity within the nanoflowers. The preparation of MNP-embedded GOx-copper hybrid nanoflowers (MNPs-GOx NFs) begins with the facile conjugation of amine-functionalized MNPs with GOx molecules via electrostatic attraction, followed by the addition of copper sulfate that leads to full blooming of the hybrid nanoflowers. In the presence of glucose, the catalytic action of GOx entrapped in the nanoflowers generates H2 O2 , which is subsequently used by peroxidase-mimicking MNPs and copper phosphate crystals, located close to GOx molecules, to convert Amplex UltraRed substrate into a highly fluorescent product. Using this strategy, the target glucose is successfully determined with excellent selectivity, stability, and magnetic reusability. This biosensor based on hybrid nanoflowers also exhibits a high degree of precision and reproducibility when applied to real human blood samples. Such novel MNP-embedded enzyme-inorganic hybrid nanoflowers have a great potential to be expanded to any oxidases, which will be highly beneficial for the detection of various other clinically important target molecules.

The use of nanoscale materials as bactericidal agents represents a novel paradigm in the development of therapeutics against drug-resistant pathogenic bacteria. In this paper the antimicrobial activity of a water soluble (gold nanoparticle)-polythiophene (AuNP-PTh) composite against common bacterial pathogens is reported. The nanocomposite is broad-spectrum in its bactericidal activity and exhibits a membrane-directed mode of action on target pathogens. The therapeutic potency of AuNP-PTh is demonstrated by experiments which reveal that the nanocomposite can breach the outer membrane defense barrier of Gram-negative pathogens for subsequent killing by a hydrophobic antibiotic, inhibit the growth of model gastrointestinal pathogens in simulated gastric fluid, and significantly eradicate bacterial biofilms. The high bacterial selectivity and lack of cytotoxicity on human cells augers well for future therapeutic application of the nanocomposite against clinically relevant pathogenic bacteria.

Synthetic amphiphiles have emerged as potent bactericidal scaffolds owing to their high propensity to interact with bacterial cells and a membrane-directed mode of action, which is likely to overcome resistance development in pathogenic bacteria. In this study, we highlighted a membrane-acting quinolinium-based cationic amphiphile (compound 1) as an adjuvant for antibiotic-mediated eradication of pathogenic bacteria and demonstrated the generation of an amphiphile-loaded nanocarrier for potential antibacterial therapy. Treatment of Gram-negative pathogenic bacteria E. coli MTCC 433 and P. aeruginosa MTCC 2488 with 1 resulted in significant augmentation of the activity of erythromycin and a decrease in the minimum inhibitory concentration of the antibiotic. Interestingly, 1 promoted large-scale eradication of P. aeruginosa MTCC 2488 biofilm and could also enhance the anti-biofilm activity of tobramycin in combination. For potential therapeutic applications, a 1-loaded bovine serum albumin-based nanocarrier was developed, which exhibited sustained release of 1 both in physiological and acidic pH and the released amphiphile displayed antibacterial as well as anti-biofilm activities. Interestingly, the nanocarrier also displayed the signature membrane-directed activity of 1 against tested pathogenic bacteria. The high bactericidal and anti-biofilm activities in conjunction with a lack of cytotoxic effect on HT-29 human cell lines enhance the merit of the amphiphile-loaded nanocarrier as a potentially therapeutic antibacterial against clinically relevant drug-resistant pathogenic bacteria.

In this paper, we present a critical assessment of the therapeutic potential of low molecular weight pyridine-based synthetic amphiphiles based on structure-guided bactericidal activity and a rational evaluation of their cytotoxic potential. Fluorescence-based structure-function studies revealed that the amphiphiles were membrane-acting and displayed a hierarchical pattern of bactericidal activity, which could be correlated with their charge density and hydrophobicity. The membrane-targeting activity of the most potent cationic amphiphile (compound 6) was vindicated as it induced extensive membrane-disruption and dissipation of the transmembrane potential (ΔΨ) in pathogenic bacteria. At concentrations equivalent to the minimum inhibitory concentration (MIC) against the Gram-positive pathogen S. aureus MTCC 96, none of the amphiphiles exerted any cytotoxic effect on model human cell lines (HeLa, MCF-7 and HT-29). However, at elevated concentrations, a distinct gradation in the cytotoxic effect was manifested, which is probably accounted by the charge density and conformational flexibility of the amphiphiles. A viable therapeutic application of compound 6 is demonstrated in combinatorial assays, wherein the proclivity of the amphiphile to disrupt bacterial membranes at very low concentration is exploited to enhance the uptake and bactericidal efficacy of erythromycin against Gram-negative pathogenic bacteria.